Everest Medicines Management
Management criteria checks 1/4
Everest Medicines' CEO is Rogers Luo, appointed in Sep 2022, has a tenure of 1.83 years. total yearly compensation is CN¥30.72M, comprised of 23.5% salary and 76.5% bonuses, including company stock and options. directly owns 0.31% of the company’s shares, worth HK$19.16M. The average tenure of the management team and the board of directors is 2.3 years and 2.8 years respectively.
Key information
Rogers Luo
Chief executive officer
CN¥30.7m
Total compensation
CEO salary percentage | 23.5% |
CEO tenure | 1.8yrs |
CEO ownership | 0.3% |
Management average tenure | 2.3yrs |
Board average tenure | 2.8yrs |
Recent management updates
Recent updates
Does Everest Medicines (HKG:1952) Have A Healthy Balance Sheet?
Apr 27Everest Medicines Limited (HKG:1952) Annual Results: Here's What Analysts Are Forecasting For This Year
Mar 31A Look At The Fair Value Of Everest Medicines Limited (HKG:1952)
Jan 31A Look At The Fair Value Of Everest Medicines Limited (HKG:1952)
Sep 26CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | CN¥31m | CN¥7m | -CN¥844m |
Sep 30 2023 | n/a | n/a | -CN¥424m |
Jun 30 2023 | n/a | n/a | -CN¥3m |
Mar 31 2023 | n/a | n/a | -CN¥125m |
Dec 31 2022 | CN¥8m | CN¥2m | -CN¥247m |
Compensation vs Market: Rogers's total compensation ($USD4.25M) is above average for companies of similar size in the Hong Kong market ($USD465.73K).
Compensation vs Earnings: Rogers's compensation has increased whilst the company is unprofitable.
CEO
Rogers Luo (54 yo)
1.8yrs
Tenure
CN¥30,722,000
Compensation
Mr. Yongqing Luo, also known as Rogers, is CEO & Executive Director of Everest Medicines Limited from September 19, 2022. He was President and General Manager of Greater China at Brii Biosciences Limited a...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 7yrs | no data | 0.60% CN¥ 37.3m | |
CEO & Executive Director | 1.8yrs | CN¥30.72m | 0.31% CN¥ 19.2m | |
CFO, President & Executive Director | 6.1yrs | CN¥18.46m | 0.063% CN¥ 4.0m | |
Chief Business Officer | 4.9yrs | no data | no data | |
Chief Scientific Officer | 3.3yrs | no data | no data | |
Chief Product Officer | less than a year | no data | no data | |
Chief Medical Officer | less than a year | no data | no data | |
Joint Company Secretary | no data | no data | no data | |
Joint Company Secretary & VP of Corporate Affairs | 2.3yrs | no data | no data |
2.3yrs
Average Tenure
51yo
Average Age
Experienced Management: 1952's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 7yrs | no data | 0.60% CN¥ 37.3m | |
CEO & Executive Director | 1.8yrs | CN¥30.72m | 0.31% CN¥ 19.2m | |
CFO, President & Executive Director | 5.6yrs | CN¥18.46m | 0.063% CN¥ 4.0m | |
Independent Non-Executive Director | 3.8yrs | CN¥401.00k | no data | |
Non-Executive Director | less than a year | no data | no data | |
Independent Non-Executive Director | 3.8yrs | CN¥401.00k | no data | |
Independent Non-Executive Director | 1.5yrs | CN¥352.00k | no data | |
Non-Executive Director | less than a year | no data | no data |
2.8yrs
Average Tenure
54.5yo
Average Age
Experienced Board: 1952's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.